MonumenTAL-3
Phase 3 Clinical Trial Comparing the Efficacy of an Investigational Medication Combined with Daratumumab or Daratumumab and Pomalidomide Versus Daratumumab, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma.
Arms / Cohorts
Arm A:Investigational Medication, Daratumumab and Pomalidomide
Accepting patients
Arm B:Daratumumab, Pomalidomide and Dexamethasone
Accepting patients
Arm C:Investigational Medication and Daratumumab
Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.